Estée Lauder’s U-turn: From offload to indie-style revival
Estée Lauder’s decision to retain indie-acquired brands Too Faced, Smashbox, and Dr. Jart+ instead of selling them marks a strategic pivot toward preserving entrepreneurial agility inside a global beauty conglomerate, reshaping acquisition logic, portfolio management, and expectations of brand autonomy in the wider indie beauty market. Estée Lauder Companies explored divestment and received final bids for a package deal that was estimated in the low nine figures—between USD 100 (approx. RM460) million and USD 199.99 (approx. RM919) million—before reversing course. Rather than cashing out of underperforming assets, the company will restructure these Estée Lauder indie brands with smaller, more focused teams and tailored operating models. That choice is less about sentimentality and more about a hard-headed bet: in a crowded color cosmetics and skincare landscape, conglomerates now believe indie-style speed is worth more than a quick sale.
Streamlined teams and the cost of chasing agility
Estée Lauder is not keeping these brands out of nostalgia; it is doing so while putting them on a strict diet. Too Faced will move its headquarters from Los Angeles to New York with a smaller team and be folded into a makeup cluster alongside Bobbi Brown and MAC. Smashbox will remain in Los Angeles with a reduced staff, while Dr. Jart+ stays in South Korea under long-time global brand lead Ye Jin Kim. These streamlined teams sit within a far larger restructuring effort: the company expects its multi-year programme to cost about USD 1.748 billion (approx. RM8.04 billion) before tax, including workforce cuts and asset-related charges. The financial pressure is plain. Net sales fell 8% for the year ended 30 June 2025 and operating margin slid from 6.2% to negative 5.5%, alongside impairments of USD 375 (approx. RM1,725) million for Dr. Jart+ and USD 50 (approx. RM230) million for Too Faced. In other words, Estée Lauder is paying dearly to find a leaner beauty brand strategy that can still support indie-like innovation.
From acquisition trophy to indie lab inside the conglomerate
Too Faced and Smashbox were once acquisition trophies, proof that legacy players could buy their way into the indie beauty market. Estée Lauder acquired Smashbox in 2010 and paid an estimated USD 1.45 billion (approx. RM6.68 billion) for Too Faced in 2016. Dr. Jart+ followed as a skin-care play, with initial investment in 2015 and full ownership by 2019. Yet over time, these brands became balance-sheet headaches rather than growth engines, contributing to impairments and falling short of internal expectations. The company’s Beauty Reimagined strategy, introduced in February 2025, is a response to that reality: it aims to restore sustainable sales growth and improve profitability by changing the operating model and market coverage. Estée Lauder’s leadership now openly argues that “adopting the speed, agility, and entrepreneurial mindset of successful beauty indies” is central to this reset. That is a telling shift—from buying indie attitude to trying to rebuild it inside corporate walls.
What this signals for big beauty and brand autonomy
The real story is less about one cancelled sale and more about a changing template for how conglomerates treat acquired indie brands. Estée Lauder is signalling that offloading underperformers is no longer the default; instead, the company is betting that lean structures and tailored business models can “accelerate innovation, strengthen consumer connections, and unlock long-term growth”. Rather than centralising everything, it is keeping Dr. Jart+ anchored where it was built and folding makeup brands into a cluster designed to share expertise but not erase identity. This approach quietly admits a decade-long miscalculation: buying indie cool is not enough if the corporate operating model suffocates the very agility consumers expect. For other legacy players, the implication is clear. Future acquisitions will be judged not only by the purchase price, but by how much autonomy and indie-style speed the parent is willing to protect over time. Estée Lauder’s indie brands are becoming test cases for that promise.
Indie agility as a long-term bet, not a quick fix
Estée Lauder’s latest outlook hints that the painful restructuring may be paying off, with raised guidance for organic net sales and adjusted profitability on the back of stronger year-to-date results for the third quarter ended 31 March 2026. But the deeper significance lies in its strategic posture: rather than treating Too Faced, Smashbox, and Dr. Jart+ as disposable assets, it is turning them into laboratories for a more flexible beauty brand strategy. By keeping these Estée Lauder indie brands and stripping back their structures, the company is betting that smaller, faster teams can do more for long-term value than a one-off sale in the low nine figures. If that bet works, it will redraw expectations for acquisition and brand autonomy across big beauty. If it fails, the impairments already booked will look modest compared with the opportunity cost. Either way, conglomerates can no longer ignore the lesson: indie agility is not a trend; it is the new operating requirement.
